Published in J Med Life on February 01, 2010
Adding thymoglobuline to the conventional immunosuppressant regimen in kidney transplantation: A cost-benefit analysis. Caspian J Intern Med (2012) 0.81
Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes. Transplantation (2015) 0.78
Current concepts in the pathophysiology and treatment of aplastic anemia. Blood (2006) 5.20
Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med (2006) 4.79
Protective conditioning for acute graft-versus-host disease. N Engl J Med (2005) 4.07
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant (2006) 2.37
Aplastic anaemia. Lancet (2005) 2.10
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia (2007) 2.07
The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function. Transplantation (2004) 1.47
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation (1998) 1.36
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes. Leukemia (2004) 1.28
Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. Biol Blood Marrow Transplant (2007) 1.26
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids. Am J Transplant (2007) 1.22
Immunosuppression: evolution in practice and trends, 1993-2003. Am J Transplant (2005) 1.17
Prednisone-free maintenance immunosuppression-a 5-year experience. Am J Transplant (2005) 1.17
Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens. Exp Hematol (2006) 1.13
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation (2003) 1.13
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects. Bone Marrow Transplant (2005) 1.13
Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transplant (2005) 1.13
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome. Leukemia (2009) 1.04
Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med (2008) 1.03
Rabbit antithymocyte globulin induction therapy in adult renal transplantation. Pharmacotherapy (2006) 1.02
Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors. Bone Marrow Transplant (2002) 1.01
A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results. Transplantation (2008) 0.99
Heterologous antilymphocyte globulin. N Engl J Med (1968) 0.97
Treatment strategies for patients with severe aplastic anemia. Bone Marrow Transplant (2008) 0.97
Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience. Transplantation (2006) 0.91
Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study. Transplantation (2004) 0.91
Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data. Transplantation (2006) 0.89
Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemia. Eur J Haematol (2008) 0.89
Long-term trends in allograft survival. Adv Chronic Kidney Dis (2006) 0.84
Mechanisms of action of antithymocyte globulin: old dogs with new tricks! Leuk Lymphoma (2008) 0.83
Current status of renal transplantation. Methods Mol Biol (2006) 0.82
Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine. Pediatr Hematol Oncol (2005) 0.80
A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients. Transpl Int (1998) 0.79
Perioperative management of immunosuppression. Surg Clin North Am (2006) 0.78
Economics of the antithymocyte globulins Thymoglobulin and Atgam in the treatment of acute renal transplant rejection. Pharmacoeconomics (2000) 0.78
Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines. Transplantation (2000) 0.76
Testicular feminization: complete androgen insensitivity syndrome. Discussions based on a case report. Rom J Morphol Embryol (2014) 0.95
Does the KDIGO CKD risk stratification based on GFR and proteinuria predict kidney graft failure? Int Urol Nephrol (2014) 0.78
Primary retroperitoneal seminoma - embryology, histopathology and treatment particularities. Rom J Morphol Embryol (2016) 0.75
Post-Finasteride Adverse Effects in Male Androgenic Alopecia: A Case Report of Vitiligo. Skin Pharmacol Physiol (2017) 0.75
Inflammatory pseudotumors of the kidney due to IgG4-related tubulointerstitial nephritis. Rom J Morphol Embryol (2014) 0.75
Polyomavirus BK-associated nephropathy after kidney transplantation: a single-center retrospective analysis. Rom J Morphol Embryol (2014) 0.75